Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond P Baumann

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Chemical Biology & Drug Design|July 23, 2011
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical propertiesPhilip G Penketh, Raymond P Baumann, Krishnamurthy Shyam, et al.
International Journal of Radiation Biology|November 25, 2011
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumorsSara Rockwell, Yanfeng Liu, Helen A Seow, et al.
Journal of Translational Science|April 15, 2016
Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell linesKimiko Ishiguro, Yong-Lian Zhu, Z Ping Lin, et al.
Biochemical Pharmacology|August 19, 2014
Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexesKimiko Ishiguro, Z Ping Lin, Philip G Penketh, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Chemical Biology & Drug Design|July 23, 2011
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine (KS119): a cytotoxic prodrug with two stable conformations differing in biological and physical propertiesPhilip G Penketh, Raymond P Baumann, Krishnamurthy Shyam, et al.
International Journal of Radiation Biology|November 25, 2011
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumorsSara Rockwell, Yanfeng Liu, Helen A Seow, et al.
Journal of Translational Science|April 15, 2016
Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell linesKimiko Ishiguro, Yong-Lian Zhu, Z Ping Lin, et al.
Biochemical Pharmacology|August 19, 2014
Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexesKimiko Ishiguro, Z Ping Lin, Philip G Penketh, et al.
Pageof 3